文献速递临床试验与 GCP流行病学与生物统计

疑似肺栓塞急诊患者中采用升高及年龄校正D-二聚体阈值的诊断策略对血栓栓塞事件的影响:一项随机临床试验

Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2021-01-01

这项在法国和西班牙18个急诊科开展的整群随机交叉非劣效性试验纳入1414例疑似肺栓塞患者,比较YEARS规则联合PERC规则及年龄校正D-二聚体阈值策略与常规年龄校正阈值策略。干预组3个月静脉血栓栓塞发生率为0.15%,对照组为0.80%,调整差值-0.64%(单侧97.5%CI,-∞至0.21%),在非劣效界值1.35%以内。

要点

  • 干预组3个月VTE发生率0.15%,对照组0.80%,调整差值-0.64%,在非劣效界值1.35%以内。
  • 干预组胸部影像检查率30.4%,对照组40.0%,调整差值-8.7%(95%CI,-13.8%至-3.5%)。
  • 干预组急诊中位停留时间6小时(IQR,4至8小时),对照组6小时(IQR,5至9小时),调整差值-1.6小时(95%CI,-2.3至-0.9)。

核心结论

  • 在疑似肺栓塞的急诊患者中,与常规诊断策略相比,对PERC阳性患者采用YEARS规则联合年龄校正D-二聚体阈值并未导致血栓栓塞事件发生率劣于对照组。

研究设计与样本

  • 整群随机、交叉、非劣效性试验,在法国和西班牙18个急诊科开展。
  • 纳入2019年10月至2020年6月期间临床低风险且未被PERC规则排除或主观临床中等风险的疑似肺栓塞患者,共1414例,随访至2020年10月。
  • 每个中心随机分配干预期和对照期的顺序;干预期726例,对照期688例。
  • 符合方案分析纳入1217例(86%);患者平均年龄55岁,女性占58%。

主要发现

  • 急诊诊断肺栓塞100例(7.1%)。
  • 3个月时,干预组1例诊断VTE(0.15%[95%CI,0.0%至0.86%]),对照组5例(0.80%[95%CI,0.26%至1.86%]),调整差值-0.64%(单侧97.5%CI,-∞至0.21%),在非劣效界值1.35%以内。
  • 6个分析的次要终点中仅2个显示干预组与对照组差异有统计学意义:胸部影像检查(30.4% vs 40.0%;调整差值-8.7%[95%CI,-13.8%至-3.5%])和急诊中位停留时间(6小时[IQR,4至8小时] vs 6小时[IQR,5至9小时];调整差值-1.6小时[95%CI,-2.3至-0.9])。

关键数值与推荐

  • 干预期:无YEARS标准且D-二聚体<1000 ng/mL的患者,或有1项及以上YEARS标准且D-二聚体低于年龄校正阈值(年龄<50岁为500 ng/mL,年龄≥50岁为年龄(岁)×10)的患者,不做胸部影像即排除肺栓塞。
  • 对照期:D-二聚体低于年龄校正阈值的患者不做胸部影像即排除肺栓塞。
  • 非劣效界值为1.35%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Uncontrolled studies suggest that pulmonary embolism (PE) can be safely ruled out using the YEARS rule, a diagnostic strategy that uses varying D-dimer thresholds. OBJECTIVE: To prospectively validate the safety of a strategy that combines the YEARS rule with the pulmonary embolism rule-out criteria (PERC) rule and an age-adjusted D-dimer threshold. DESIGN, SETTINGS, AND PARTICIPANTS: A cluster-randomized, crossover, noninferiority trial in 18 emergency departments (EDs) in France and Spain. Patients (N = 1414) who had a low clinical risk of PE not excluded by the PERC rule or a subjective clinical intermediate risk of PE were included from October 2019 to June 2020, and followed up until October 2020. INTERVENTIONS: Each center was randomized for the sequence of intervention periods. In the intervention period (726 patients), PE was excluded without chest imaging in patients with no YEARS criteria and a D-dimer level less than 1000 ng/mL and in patients with 1 or more YEARS criteria and a D-dimer level less than the age-adjusted threshold (500 ng/mL if age <50 years or age in years × 10 in patients ≥50 years). In the control period (688 patients), PE was excluded without chest imaging if the D-dimer level was less than the age-adjusted threshold. MAIN OUTCOMES AND MEASURES: The primary end point was venous thromboembolism (VTE) at 3 months. The noninferiority margin was set at 1.35%. There were 8 secondary end points, including chest imaging, ED length of stay, hospital admission, nonindicated anticoagulation treatment, all-cause death, and all-cause readmission at 3 months. RESULTS: Of the 1414 included patients (mean age, 55 years; 58% female), 1217 (86%) were analyzed in the per-protocol analysis. PE was diagnosed in the ED in 100 patients (7.1%). At 3 months, VTE was diagnosed in 1 patient in the intervention group (0.15% [95% CI, 0.0% to 0.86%]) vs 5 patients in the control group (0.80% [95% CI, 0.26% to 1.86%]) (adjusted difference, -0.64% [1-sided 97.5% CI, -∞ to 0.21%], within the noninferiority margin). Of the 6 analyzed secondary end points, only 2 showed a statistically significant difference in the intervention group compared with the control group: chest imaging (30.4% vs 40.0%; adjusted difference, -8.7% [95% CI, -13.8% to -3.5%]) and ED median length of stay (6 hours [IQR, 4 to 8 hours] vs 6 hours [IQR, 5 to 9 hours]; adjusted difference, -1.6 hours [95% CI, -2.3 to -0.9]). CONCLUSIONS AND RELEVANCE: Among ED patients with suspected PE, the use of the YEARS rule combined with the age-adjusted D-dimer threshold in PERC-positive patients, compared with a conventional diagnostic strategy, did not result in an inferior rate of thromboembolic events. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04032769.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Freund Y, Chauvin A, Jimenez S, et al. Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial. JAMA. 2021. PMID: 34874418. doi:10.1001/jama.2021.20750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。